237 results
Page 11 of 12
6-K
EX-99
6wp81c zhi2b5rj0mzz
9 Sep 13
BioLineRx’s BL-8040 Receives Orphan Drug
12:00am
6-K
EX-99
uq2yqs 2r5qe
3 Sep 13
BioLineRx Announces Issuance of United States Patent
12:00am
424B3
c4hlc930vye6ap56u832
8 Aug 13
Prospectus supplement
12:00am
6-K
EX-99
erptrhd2w
6 Aug 13
BioLineRx Reports Second Quarter 2013 Results
12:00am
6-K
EX-99
zmir2bso hydxe
10 Jun 13
Current report (foreign)
12:00am
6-K
EX-10.1
1o57rjglx 4tp
17 May 13
BioLineRx Enters into “At-The-Market” Offering
12:00am
424B5
dafcu
17 May 13
Prospectus supplement for primary offering
12:00am
424B5
ltsf808436 v4w
17 May 13
Prospectus supplement for primary offering
12:00am
6-K
EX-99
6rv4b
7 May 13
BioLineRx Reports First Quarter 2013 Results
12:00am
6-K
EX-99
0qnqr
30 Apr 13
Current report (foreign)
12:00am
6-K
EX-99
7debrgmupqledw
20 Mar 13
BioLineRx Announces Results from Interim Analysis of
12:00am
6-K
EX-99
x173 1yvi3mcsqs
12 Mar 13
BioLineRx Reports Year End 2012 Financial Results
12:00am
424B5
zhgqqzpwcpp90wxm5br
6 Feb 13
Prospectus supplement for primary offering
12:00am
424B3
4n8u0bpiqs iivgjwz4d
15 Oct 12
Prospectus supplement
12:00am
F-1
gktw98 mkd
2 Oct 12
Registration statement (foreign)
12:00am
6-K
EX-99.1
ot6lwos0yt43w
27 Sep 12
Current report (foreign)
12:00am
6-K
EX-99
ct69jk cmhrq1
15 Aug 12
BioLineRx Reports Second Quarter 2012 Results
12:00am
F-3
pyaqtmlhmb2 jr
1 Aug 12
Shelf registration (foreign)
12:00am
424B3
g87ux4ml
28 Mar 12
Prospectus supplement
12:00am